CD33 and acute myeloid leukemia: It is worth mentioning an innovative design by Teppert et al. using T cells co-transduced with a CD33 CAR and a mutant nucleophosmin 1 TCR (dNPM1-TCR) that specifically recognizes the AML neo-epitope CLAVEEVSL [158].